Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo B Mansur

Showing results (1-10 of 256) with videos related to

Pageof 26
Sort By:
Journal of Affective Disorders|March 16, 2013
Determinants of adherence to treatment in bipolar disorder: a comprehensive reviewEmilie Leclerc, Rodrigo B Mansur, Elisa Brietzke
CNS Spectrums|December 20, 2015
Treating to target in major depressive disorder: response to remission to functional recoveryRoger S McIntyre, Yena Lee, Rodrigo B Mansur
Neuroscience and Biobehavioral Reviews|January 13, 2015
Is there a "metabolic-mood syndrome"? A review of the relationship between obesity and mood disordersRodrigo B Mansur, Elisa Brietzke, Roger S McIntyre
CNS Spectrums|January 4, 2017
A pragmatic approach to the diagnosis and treatment of mixed features in adults with mood disordersRoger S McIntyre, Yena Lee, Rodrigo B Mansur
Neuroscience and Biobehavioral Reviews|April 20, 2020
What is bipolar disorder? A disease model of dysregulated energy expenditureRodrigo B Mansur, Yena Lee, Roger S McIntyre, et al.
Neuroscience and Biobehavioral Reviews|August 24, 2017
Gluten related illnesses and severe mental disorders: a comprehensive reviewElisa Brietzke, Raphael O Cerqueira, Rodrigo B Mansur, et al.
CNS & Neurological Disorders Drug Targets|December 4, 2014
Are major depressive disorder and diabetes mellitus amyloidogenic conditions?Anusha Baskaran, Andre F Carvalho, Rodrigo B Mansur, et al.
Neuropharmacology|February 27, 2018
Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon-like peptide 1 receptor agonists?Rodrigo B Mansur, Yena Lee, Mehala Subramaniapillai, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 29, 2014
Inflamed moods: a review of the interactions between inflammation and mood disordersJoshua D Rosenblat, Danielle S Cha, Rodrigo B Mansur, et al.
Reviews in the Neurosciences|September 5, 2012
N-acetylcysteine as a potentially useful medication to prevent conversion to schizophrenia in at-risk individualsElson Asevedo, Graccielle R Cunha, André Zugman, et al.
Pageof 26

Showing results (1-10 of 256) with videos related to

Sort By:
Pageof 26
Journal of Affective Disorders|March 16, 2013
Determinants of adherence to treatment in bipolar disorder: a comprehensive reviewEmilie Leclerc, Rodrigo B Mansur, Elisa Brietzke
CNS Spectrums|December 20, 2015
Treating to target in major depressive disorder: response to remission to functional recoveryRoger S McIntyre, Yena Lee, Rodrigo B Mansur
Neuroscience and Biobehavioral Reviews|January 13, 2015
Is there a "metabolic-mood syndrome"? A review of the relationship between obesity and mood disordersRodrigo B Mansur, Elisa Brietzke, Roger S McIntyre
CNS Spectrums|January 4, 2017
A pragmatic approach to the diagnosis and treatment of mixed features in adults with mood disordersRoger S McIntyre, Yena Lee, Rodrigo B Mansur
Neuroscience and Biobehavioral Reviews|April 20, 2020
What is bipolar disorder? A disease model of dysregulated energy expenditureRodrigo B Mansur, Yena Lee, Roger S McIntyre, et al.
Neuroscience and Biobehavioral Reviews|August 24, 2017
Gluten related illnesses and severe mental disorders: a comprehensive reviewElisa Brietzke, Raphael O Cerqueira, Rodrigo B Mansur, et al.
CNS & Neurological Disorders Drug Targets|December 4, 2014
Are major depressive disorder and diabetes mellitus amyloidogenic conditions?Anusha Baskaran, Andre F Carvalho, Rodrigo B Mansur, et al.
Neuropharmacology|February 27, 2018
Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon-like peptide 1 receptor agonists?Rodrigo B Mansur, Yena Lee, Mehala Subramaniapillai, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 29, 2014
Inflamed moods: a review of the interactions between inflammation and mood disordersJoshua D Rosenblat, Danielle S Cha, Rodrigo B Mansur, et al.
Reviews in the Neurosciences|September 5, 2012
N-acetylcysteine as a potentially useful medication to prevent conversion to schizophrenia in at-risk individualsElson Asevedo, Graccielle R Cunha, André Zugman, et al.
Pageof 26